Related Experiment Video
Updated: Jan 29, 2026

Screening and Identification of RNA Silencing Suppressors from Secreted Effectors of Plant Pathogens
Published on: February 3, 2020
Genome-Wide Screening and Functional Analysis Identifies Tumor Suppressor Long Noncoding RNAs Epigenetically Silenced
Feiyue Xu1, Chi Han Li1, Chi Hin Wong1
1School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
Abstract:
Long noncoding RNAs (lncRNA) play critical roles in the development of cancer, including hepatocellular carcinoma (HCC). However, the mechanisms underlying their deregulation remain largely unexplored. In this study, we report that two lncRNAs frequently downregulated in HCC function as tumor suppressors and are epigenetically silenced by histone methyltransferase EZH2. lncRNAs TCAM1P-004 and RP11-598D14.1 were inhibited by EZH-mediated trimethylation of H3K27me3 at their promoters. Downregulation of TCAM1P-004 and RP11-598D14.1 was frequently observed in HCC tumors compared with adjacent normal tissues. Both lncRNAs inhibited cell growth, cell survival, and transformation in HCC cells in vitro as well as tumor formation in vivo. Using RNA pull-down and mass spectrometry, we demonstrated that TCAM1P-004 bound IGF2BP1 and HIST1H1C, whereas RP11-598D14.1 bound IGF2BP1 and STAU1. These lncRNA-protein interactions were critical in regulating p53, MAPK, and HIF1α pathways that promoted cell proliferation in HCC. Overexpression of EZH2 was critical in repressing TCAM1P-004 and RP11-598D14.1, and EZH2-TCAM1P-004/RP11-598D14.1-regulated pathways were prevalent in human HCC. Aberrant suppression of TCAM1P-004 and RP11-598D14.1 led to loss of their tumor-suppressive effects by disrupting the interaction with IGF2BP1, HIST1H1C, and STAU1, which in turn promoted HCC development and progression. Collectively, these findings demonstrate the role of TCAMP1P-004 and RP11-598D14.1 in suppressing tumor growth and suggest that EZH2 may serve as a therapeutic target in HCC. SIGNIFICANCE: EZH2-mediated loss of lncRNAs TCAM1P-004 and RP11-598D14.1 hinders the formation of tumor suppressor lncRNA-protein complexes and subsequently promotes HCC growth.
Insights
Two long noncoding RNAs (lncRNAs), TCAM1P-004 and RP11-598D14.1, act as tumor suppressors in hepatocellular carcinoma (HCC). They are epigenetically silenced by EZH2, and their loss promotes HCC growth, suggesting EZH2 as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Long noncoding RNAs (lncRNAs) are implicated in cancer development, but their specific roles and regulatory mechanisms in hepatocellular carcinoma (HCC) are not fully understood.
- Deregulation of lncRNAs, particularly their downregulation, is a common event in cancer progression.
Purpose of the Study:
- To investigate the function of frequently downregulated lncRNAs in HCC.
- To elucidate the epigenetic mechanisms responsible for lncRNA deregulation in HCC.
- To identify potential therapeutic targets for HCC treatment.
Main Methods:
- Quantitative analysis of lncRNA expression in HCC tumors and adjacent normal tissues.
- Chromatin immunoprecipitation (ChIP) assays to assess histone modifications (H3K27me3) at lncRNA promoters.
- In vitro and in vivo assays to evaluate the tumor-suppressive functions of lncRNAs.
- RNA pull-down assays coupled with mass spectrometry to identify lncRNA-protein interactions.
- Analysis of signaling pathways regulated by lncRNA-protein complexes.
Main Results:
- TCAM1P-004 and RP11-598D14.1 were significantly downregulated in HCC tissues.
- EZH2-mediated H3K27 trimethylation at the promoters of TCAM1P-004 and RP11-598D14.1 led to their silencing.
- Both lncRNAs exhibited tumor-suppressive activities by inhibiting cell growth, survival, and transformation in HCC.
- TCAM1P-004 interacted with IGF2BP1 and HIST1H1C; RP11-598D14.1 interacted with IGF2BP1 and STAU1.
- These interactions were crucial for regulating proliferation-associated pathways (p53, MAPK, HIF1α).
- Overexpression of EZH2 correlated with repression of these lncRNAs and promoted HCC progression.
Conclusions:
- TCAM1P-004 and RP11-598D14.1 function as tumor suppressors in HCC by forming complexes with specific proteins.
- Epigenetic silencing of these lncRNAs by EZH2 contributes to HCC development and progression.
- Targeting EZH2 may represent a viable therapeutic strategy for HCC.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
piRNA - Piwi-interacting RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
lncRNA - Long Non-coding RNAs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

